Others titles
- NGC Guideline Summaries
- Evidence-based Clinical Practice Guidelines
- Guidline Summaries by Clinical Speciality
- Guidline Summaries by Category
- Guidline Summaries by Intended Users
Keywords
- Clinical Guidelines
- Practice Guidelines
- Guideline Attributes
- Inclusion Criteria
- Guideline Summary
- MESH Terminology
Clinical Practice Guideline Summaries
This dataset contains summaries of evidence-based clinical practice guidelines. Clinical practice guidelines are statements that include recommendations intended to optimize patient care that is informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options. See also the similar dataset Nursing Order Sets Data Package.
Get The Data
- ResearchNon-Commercial, Share-Alike, Attribution Free Forever
- CommercialCommercial Use, Remix & Adapt, White Label Log in to download
Description
National Guideline Clearinghouse (NGC) provides structured summaries containing information from clinical practice guidelines. NGC is an initiative of the Agency for Healthcare Research and Quality (AHRQ),U.S. Department of Health and Human Services.
NGC supports AHRQ’s mission to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable by providing objective, detailed information on clinical practice guidelines, and to further their dissemination, implementation, and use in order to inform health care decisions.
NGC uses a systematic approach to decide when it is appropriate to include author, year citations in the Major Recommendations field and full citations in the References Supporting the Recommendations field. Two criteria drive the decision-making process: (1) the recommendations are explicitly stated, and (2) those explicit statements are referenced. The first criterion means that the recommendations in the guideline document are easily identified, stand-alone and action-oriented statements. Explicit recommendation statements are not interspersed among rationale in the guideline document. The rationale for the recommendations may be provided in sections before or after the actual recommendations but not within the same body of content as the recommendations. The second criterion means that the reference(s) supporting the explicit recommendation is (are) provided at the end of the statement. References cited in the rationale for the recommendation are not captured.
NGC’s master’s level indexers apply terms from selected UMLS vocabularies to each guideline summary to facilitate searching and browsing and to create relationships between similar documents. These vocabularies are:
-Healthcare Common Procedure Coding System (HCPCS)
-International Classification of Diseases – Clinical Modification (ICD-9-CM)
-Medical Subject Headings (MeSH)
-Physician Data Query (PDQ)
-Standard Product Nomenclature (SPN)
-Systemized Nomenclature of Medicine (Clinical Terms) (SNOMED CT)
-UMLS Metathesaurus (MTH)
-Universal Medical Device Nomenclature System (UMDNS)
As part of the NGC Annual Verification, many guidelines are withdrawn from the Web site at the end of every year because they no longer meet the Inclusion Criteria with respect to date. NGC’s inclusion criteria specifically require that guidelines represented in their database have been developed, reviewed, or revised within the last five years. All guidelines that no longer meet this criterion are removed from the Web site at the end of each calendar year.
About this Dataset
Data Info
Date Created | 1997 |
---|---|
Last Modified | 2018-07-02 |
Version | 2018-07-02 |
Update Frequency |
Never |
Temporal Coverage |
N/A |
Spatial Coverage |
N/A |
Source | John Snow Labs; National Guideline Clearinghouse (NGC); |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | Clinical Guidelines, Practice Guidelines, Guideline Attributes, Inclusion Criteria, Guideline Summary, MESH Terminology |
Other Titles | NGC Guideline Summaries, Evidence-based Clinical Practice Guidelines, Guidline Summaries by Clinical Speciality, Guidline Summaries by Category, Guidline Summaries by Intended Users |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Guideline_ID | The Guideline unique identifier | integer | required : 1level : Nominal |
Guideline_Title | Identifies the complete title of the guideline. | string | required : 1 |
Bibliographic_Sources | Identifies the complete bibliographic source(s) for the published guideline as disseminated by the guideline developer(s). The number of references cited is included for each source. | string | - |
Guideline_Status | Identifies the current status of the summary including whether the guideline is an updated version of a previously issued document, whether an update is in progress, and whether the guideline meets the 2013 (revised) inclusion criteria. | string | - |
Regulatory_Alert | Identifies important warnings and/or revised regulatory information released by the U.S. Food and Drug Administration (FDA) or other official regulatory body for a drug and/or device for which recommendations are provided in the original guideline document. | string | - |
Scope_Disease_Conditions | Identifies the major areas of clinical medicine or health care addressed in the guideline. Values are expressed using the natural language expressions found in the text of the guideline. | string | - |
Scope_Other_Disease_Conditions | Indicates the presence of multiple chronic conditions by listing co-existing or comorbid chronic diseases or conditions for which specific recommendations are provided. | string | - |
Scope_Guideline_Category | Classifies the major focus of the guideline. Values are selected from the appropriate concepts in the Classification Scheme. | string | - |
Scope_Clinical_Speciality | Classifies the clinical specialties that might use the guideline professionally. Values are selected from the appropriate concepts in the Classification Scheme. | string | - |
Scope_Intended_Users | Classifies the groups intended to use the guideline. Values are selected from the appropriate concepts in the Classification Scheme. | string | - |
Scope_Guideline_Objectives | Describes the objectives of the guideline as specified in the original guideline document. | string | - |
Scope_Target_Population | Describes the target population(s) addressed in the guideline. | string | - |
Scope_Interventions_and_Practices_Considered | Identifies the specific clinical interventions and practices considered in the guideline. Values are expressed using natural language expressions found in the text of the guideline. | string | - |
Scope_Major_Outcomes_Considered | Describes the most important specific outcomes or performance measures considered in the guideline. Includes patient outcomes described in treatment guidelines and diagnostic test performance characteristics described in diagnosis or screening guidelines. | string | - |
Methodology_Evidence | Classifies the methods used to collect and select the evidence that were evaluated. Values are selected from the appropriate concepts in the Classification Scheme. | string | - |
Methodology_Description_Evidence | Describes/summarizes the specific methods used to collect and select the evidence, as identified in the text of the guideline or by the guideline developer. Can include detailed search strategies, lists of journals scanned, keywords, database sources, inclusion and exclusion criteria, etc. | string | - |
Methodology_Number_of_Documents | Identifies the number of source documents that were identified by the methods described above under "Methodology_Description_Evidence". | string | - |
Methodology_Quality_and_Strength_Evidence | Classifies the methods used by the guideline developer to determine what relative importance to give the evidence they obtained. Values are selected from the appropriate concepts in the Classification Scheme. | string | - |
Methodology_Rating_Scheme_Evidence | Presents the rating scheme for strength of evidence, when given. | string | - |
Methodology_Analysis | Classifies the methods used by the guideline developer to evaluate the data in the evidence they obtained. Values are selected from the appropriate concepts in the Classification Scheme. | string | - |
Methodology_Description_Analysis | Describes the methods used to analyze the evidence. Presents additional definition for the values presented under "Methodology_Analysis" (for example, defines "systematic" or summarizes the details of the meta-analyses). | string | - |
Methodology_Recommendations | Identifies the methods used to translate evidence into statements that will assist practitioners and patients in making decisions about appropriate health care for specific clinical circumstances. Values are selected from the appropriate concepts in the Classification Scheme. | string | - |
Methodology_Description_Recommendations | Captures the details of the methods used to translate evidence into recommendation statements. Issues considered by the guideline developers during recommendation formulation such as cost, patient preference, and values, are also captured. | string | - |
Methodology_Rating_Scheme_Recommendations | Captures the weighted scheme used by the guideline developer to determine what relative strength or importance to give to the recommendations being made. | string | - |
Methodology_Cost_Analysis | Describes any formal cost analysis performed and any published cost analyses reviewed. | string | - |
Methodology_Guideline_Validation | Lists the method(s) used to validate the recommendations of the guideline. | string | - |
Methodology_Description_Guideline_Validation | Captures the details of the method(s) used by the guideline developer to validate the guideline. | string | - |
Recommendations_Major | Identifies the major recommendations of the guideline. | string | - |
Recommendations_Clinical_Algorithms | Identifies the recommendations expressed in the form of clinical algorithm(s) and where the algorithm(s) are provided | string | - |
Supporting_Recommendations_References | Lists the references of evidence supporting the recommendations when applicable. This field opens in a new window and PubMed links are provided when available. | string | - |
Supporting_Recommendations_Evidence_Type | Describes the type of evidence supporting the recommendations. | string | - |
Implementing_Recommendations_Potential_Benefits | Describes the anticipated benefits associated with implementing the guideline's recommendations. When applicable, the field also includes information on the major subgroup(s) of patients within the target population most likely to benefit from the guideline recommendations. | string | - |
Implementing_Recommendations_Potential_Harms | Description of the anticipated harms, potential risks or adverse consequences associated with the guideline's recommendations, as stated in the guideline text, to target populations or intended users. | string | - |
Contraindications | Identifies the instances (e.g., co-morbidities) that might render the use of medications or procedures improper, undesirable, or inadvisable. | string | - |
Qualifying_Statements | Presents qualifying statements or important caveats pertaining to the major recommendations of the guideline. Identifies areas of uncertainty and presents a brief description of how the guideline developer addressed this uncertainty in developing the recommendations. | string | - |
Guidelines_Implementation_Strategy | Describes specific strategies, aims, performance measures, or plans for implementing the guideline recommendations. | string | - |
Guidelines_Implementation_Tools | Identifies the types of implementation tools provided by the guideline developer to facilitate the implementation of the guideline. Values are selected from the appropriate concepts in the Classification Scheme | string | - |
Guidelines_Implementation_NQMC_Measures | Identifies link(s) to related quality measures in the National Quality Measures Clearinghouse™ (NQMC). | string | - |
IOM_Care_Need | Classifies the guideline into one of four Institute of Medicine (IOM) care need classifications: End of life care; Getting better; Living with illness; Staying healthy. | string | - |
IOM_Domain | Classifies the guideline into one or more of the four Institute of Medicine (IOM) care domains: Effectiveness; Patient-centeredness; Safety; Timeliness. | string | - |
Information_Adaptation | Identifies that the guideline has been adapted from another guideline and identifies the source document. | string | - |
Information_Date_Released | Identifies the date the guideline was released to the public. | string | - |
Information_Guideline_Developers | Identifies the organization(s) responsible for the development of the guideline. | string | - |
Information_Guideline_Developers_Comment | If the guideline developer is a consortium or represents a group of organizations, this field identifies the individual organizations by name. | string | - |
Information_Source_Funding | Identifies source(s) of financial support for guideline development, as identified in the guideline text or by the guideline developer. Lists any gran numbers associated with funding, as identified in the guideline text or by the guideline developer. | string | - |
Information_Guideline_Committee | Identifies formal name, if any, of committee/subcommittee within the guideline developer organization(s) responsible for developing the guideline. | string | - |
Information_Guideline_Author_Group | Describes the composition of the group/committee that authored the guideline, including professional degrees and affiliations, and lists the names of individual committee members, where given. | string | - |
Information_Conflicts_of_Interest | Captures relationships between individuals of the guideline development committee/group and for-profit and not-for-profit companies or organizations that could potentially influence that individual's contribution to the guideline's development. | string | - |
Information_Endorsers | Identifies organization(s) that have endorsed the guideline. Each organization is classified by the major designation or function (derived from the Organization Type attribute), such as "Medical Specialty Society" or "Professional Association." | string | - |
Information_Guideline_Availability | Identifies information about the availability of the guideline. Provides links to the full-text document and ordering information for print copies. | string | - |
Information_Companion_Document_Availability | Identifies the companion documents produced by the guideline developer that are considered relevant to the guideline. | string | - |
Information_Patient_Resources | Identifies patient resources that are directly related (i.e., derived and/or prepared from the guideline by the guideline developer) to the guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content. | string | - |
Information_NGC_Status | Identifies when the guideline was completed or revised by ECRI Institute, and verified by the developing organization(s). | string | - |
Information_Copyright_Statement | Provides the copyright statement of the organization that submitted the guideline. | string | - |
NGC_Disclaimer | Provides disclaimer information about the relationship between NGC (including its sponsor, the Agency for Healthcare Research and Quality (AHRQ), and its contractor, ECRI Institute) and the guidelines and guideline developers represented on the Web site. | string | - |